AA
ARNA

AlphaMark Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

AlphaMark Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$2K – 521
2018
Q3 		$2K Hold
50
– – ﹤0.01% 482
2018
Q2 		$2K Hold
50
– – ﹤0.01% 496
2018
Q1 		$2K Buy
+50
New +$1.95K ﹤0.01% 486

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AlphaMark Advisors's ARNA Position: Q4 2018 in Review

AlphaMark Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2018, closing a stake of 50 shares — an estimated $2K sold.

AlphaMark Advisors first reported a position in ARNA in Q1 2018 and held it in 3 quarters. The position peaked at $2K in Q3 2018. 177 funds tracked by Wall St. Rank hold ARNA as of Q4 2018.

  • AlphaMark Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • AlphaMark Advisors sold 50 Arena Pharmaceuticals Inc shares in Q4 2018, an estimated $2K.
  • AlphaMark Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 3 quarters.
  • AlphaMark Advisors's Arena Pharmaceuticals Inc position peaked at $2K in Q3 2018.
  • 177 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2018.

Based on AlphaMark Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.